Circulating Th1, Th2, and Th17 Levels in Hypertensive Patients
Table 1
Clinical characteristics of patients.
Characteristics
Control ()
HT ()
Dipper ()
Nondipper ()
NCAP ()
CAP ()
Age (years)
47.7 ± 9.0
46.4 ± 13.5
44.2 ± 16.7
48.1 ± 10.3
40.0 ± 10.1
56.9 ± 11.9*
Sex (male/female)
7/8
27/18
11/9
16/9
16/9
16/9
Year of hypertension (years)
—
10.2 ± 9.2
11.8 ± 10.7
8.9 ± 7.9
6.6 ± 6.2
16.1 ± 10.5
Office SBP (mm Hg)
112 ± 9.0
143 ± 19
144 ± 17
143 ± 20
144 ± 19
142 ± 18
Office DBP (mm Hg)
74 ± 9.0
92 ± 16
93 ± 15
91 ± 17
96 ± 15
85 ± 15
Heart rate (beats/min)
67 ± 6
70 ± 8
71 ± 9
69 ± 7
71 ± 6
67 ± 10
BMI (kg/m2)
23.11 ± 2.12
26.79 ± 3.58
26.97 ± 3.50
26.64 ± 3.71
26.68 ± 4.14
26.96 ± 2.51
TG (mmol/L)
1.71 ± 1.56
1.98 ± 2.18
1.96 ± 1.49
2.00 ± 2.64
1.84 ± 1.59
2.20 ± 2.95
TC (mmol/L)
4.42 ± 0.74
4.62 ± 0.74
4.66 ± 0.74
4.59 ± 0.76
4.51 ± 0.57
4.79 ± 0.96
LDL-C (mmol/L)
2.47 ± 0.73
2.84 ± 0.62
2.91 ± 0.66
2.79 ± 0.6
2.79 ± 0.65
2.93 ± 0.57
HDL-C (mmol/L)
1.25 ± 0.3
1.06 ± 0.26
1.07 ± 0.25
1.05 ± 0.28
1.04 ± 0.27
1.08 ± 0.24
GLU (mmol/L)
5.37 ± 0.35
5.33 ± 0.65
5.23 ± 0.57
5.41 ± 0.71
5.18 ± 0.62
5.59 ± 0.64
HbA1c (%)
5.37 ± 0.39
5.47 ± 0.51
5.37 ± 0.4
5.55 ± 0.58
5.32 ± 0.49
5.71 ± 0.46
Creatinine (μmol/L)
71.33 ± 14.48
77.42 ± 32.11
73.06 ± 18.88
80.92 ± 39.75
79.12 ± 38.24
74.62 ± 18.83
CRP (mg/L)
0.64 ± 0.77
2.42 ± 3.53
1.77 ± 1.95
2.94 ± 4.39
2.23 ± 3.73
2.73 ± 3.27
Hcy (pg/ml)
11.27 ± 4.75
16.38 ± 7.14
18.05 ± 9.18
15.04 ± 4.76
17.7 ± 8.31
14.20 ± 3.96
Ang II (pg/ml)
37.71 ± 8.69
69.61 ± 35.39
72.65 ± 44.08
67.17 ± 27.28
69.54 ± 40.90
69.72 ± 24.93
Medical treatments, n (%)
ACEI/ARB
—
30 (66.7)
14 (70)
16 (64)
15 (53.6)
15 (88.2)
β-Blocker
—
24 (53.3)
10 (50)
14 (56)
15 (53.6)
9 (52.9)
CCB
—
33 (73.3)
14 (70)
19 (76)
19 (67.9)
14 (82.3)
Diuretics
—
11 (24.4)
2 (10)
9 (36)
4 (14.3)
7 (41.2)
Note: the data are given as the mean ± SD or number of patients. SBP: systolic blood pressure; DBP: diastolic blood pressure; BMI: body mass index; TG: total triglycerides; TC: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; GLU: fasting glucose; CRP: C-reactive protein; Hcy: homocysteine; Ang II: angiotensin II; ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker; CCB: calcium channel blocker. versus control.
